Novel mobility test to assess functional vision in patients with inherited retinal dystrophies
暂无分享,去创建一个
Jean Bennett | Zi-Fan Yu | Kathleen A. Marshall | J. Bennett | D. Chung | K. High | J. Wellman | Sarah Mccague | Daniel C Chung | Kathleen Marshall | Katherine A High | Sarah McCague | Satha Thill | Julie DiStefano-Pappas | Dominique Cross | Jennifer Wellman | Julie DiStefano-Pappas | Dominique Cross | Zi-Fan Yu | Satha Thill | Zi‐Fan Yu
[1] Gislin Dagnelie,et al. Orientation and Mobility Assessment in Retinal Prosthetic Clinical Trials , 2012, Optometry and vision science : official publication of the American Academy of Optometry.
[2] E.W. Hill,et al. Mobility in Individuals with Moderate Visual Impairments , 1990 .
[3] J. Lovie-Kitchin,et al. What areas of of the visual field are important for mobility in low vision patients , 1990 .
[4] Stacey George,et al. Vision-Related Quality of Life in Patients with Complete Homonymous Hemianopia Post Stroke , 2009, Topics in stroke rehabilitation.
[5] C I Howarth,et al. The efficiency and walking speed of visually impaired people. , 1986, Ergonomics.
[6] Shirin E. Hassan,et al. Visual Field Size Criteria for Mobility Rehabilitation Referral , 2010, Optometry and vision science : official publication of the American Academy of Optometry.
[7] Kathleen A. Marshall,et al. Safety and efficacy of gene transfer for Leber's congenital amaurosis. , 2008, The New England journal of medicine.
[8] Gang Luo,et al. Evaluation of a Portable Collision Warning Device for Patients With Peripheral Vision Loss in an Obstacle Course. , 2015, Investigative ophthalmology & visual science.
[9] Celia S. Chen,et al. Functional improvements following the use of the NVT Vision Rehabilitation program for patients with hemianopia following stroke. , 2012, NeuroRehabilitation.
[10] J. Lovie-Kitchin,et al. Mobility performance with retinitis pigmentosa , 1997 .
[11] A. Munnich,et al. Leber congenital amaurosis. , 1999, Molecular genetics and metabolism.
[12] Jan E Lovie-Kitchin,et al. Visual Function, Visual Attention, and Mobility Performance in Low Vision , 2008, Optometry and vision science : official publication of the American Academy of Optometry.
[13] I. Bailey,et al. Visual Factors and Orientation‐Mobility Performance , 1982, American journal of optometry and physiological optics.
[14] S. Haymes,et al. Mobility of People with Retinitis Pigmentosa as a Function of Vision and Psychological Variables , 1996, Optometry and vision science : official publication of the American Academy of Optometry.
[15] Kathleen A. Marshall,et al. Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial , 2017, The Lancet.
[16] K. Turano,et al. Traditional Measures of Mobility Performance and Retinitis Pigmentosa , 1998, Optometry and vision science : official publication of the American Academy of Optometry.
[17] W. Hauswirth,et al. Advancing therapeutic strategies for inherited retinal degeneration: recommendations from the Monaciano Symposium. , 2015, Investigative ophthalmology & visual science.
[18] J. L. Elliott,et al. Visual Correlates of Mobility in Real World Settings in Older Adults with Low Vision , 1998, Optometry and vision science : official publication of the American Academy of Optometry.
[19] Jean Bennett,et al. Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial , 2016, The Lancet.
[20] Christian J Foy. Does mobility performance of visually impaired adults improve immediately after orientation and mobility training? , 2002, Optometry and vision science : official publication of the American Academy of Optometry.
[21] Kathleen A. Marshall,et al. Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial , 2009, The Lancet.